Table 1.
Clinicopathological Features of the Cohort | n = 314 n (%) |
---|---|
Age (median, range) | 65, 29–94 |
Gender | |
Female | 112 (35.67%) |
Male | 202 (64.33%) |
Clinical stage | |
I | 6 (1.91%) |
II | 6 (1.91%) |
III | 17 (5.41%) |
IV | 271 (86.31%) |
NA | 14 (4.46%) |
T stage | |
1 | 13 (4.14%) |
2 | 22 (7.01%) |
3 | 16 (5.09%) |
4 | 48 (15.29%) |
NA | 215 (68.47%) |
N stage | |
0 | 13 (4.14%) |
1 | 4 (1.27%) |
2 | 32 (10.19) |
3 | 52 (16.56%) |
NA | 213 (67.84%) |
M stage | |
0 | 20 (6.67%) |
1 | 78 (24.84%) |
NA | 216 (68.79%) |